Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-22-000334
Filing Date
2022-01-19
Accepted
2022-01-19 16:31:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 18578
2 GRAPHIC g211954g20r19.jpg GRAPHIC 9040
  Complete submission text file 0000950123-22-000334.txt   32059
Mailing Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027
Business Address 1800 EL CAMINO REAL, SUITE D MENLO PARK CA 94027 (650) 331-9090
AN2 Therapeutics, Inc. (Filer) CIK: 0001880438 (see all company filings)

EIN.: 820606654 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2834 Pharmaceutical Preparations